Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Therapeutics (LENZ) over the last 5 years, with Dec 2024 value amounting to $27.5 million.

  • Therapeutics' Shares Outstanding (Weighted Average) fell 0.27% to $8.3 million in Q4 2023 from the same period last year, while for Sep 2023 it was $8.3 million, marking a year-over-year decrease of 0.40%. This contributed to the annual value of $27.5 million for FY2024, which is 231.93% up from last year.
  • Per Therapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $27.5 million for FY2024, which was up 231.93% from $8.3 million recorded in FY2023.
  • Over the past 5 years, Therapeutics' Shares Outstanding (Weighted Average) peaked at $27.5 million during FY2024, and registered a low of $7.8 million during FY2020.
  • For the 3-year period, Therapeutics' Shares Outstanding (Weighted Average) averaged around $14.7 million, with its median value being $8.3 million (2022).
  • In the last 5 years, Therapeutics' Shares Outstanding (Weighted Average) fell by 0.27% in 2023 and then surged by 231.93% in 2024.
  • Yearly analysis of 5 years shows Therapeutics' Shares Outstanding (Weighted Average) stood at $7.8 million in 2020, then climbed by 6.61% to $8.3 million in 2021, then grew by 0.13% to $8.3 million in 2022, then fell by 0.27% to $8.3 million in 2023, then surged by 231.93% to $27.5 million in 2024.